Home » Business Information » Costs & Rebates » MTPConnect REDI Subsidy

A new funding partnership between APR.Intern and MedTech and Pharma Growth Centre (MTPConnect) will increase workforce capabilities and strengthen research translation within Australia’s medtech, biotech and pharmaceutical sector.

Under the agreement, MTPConnect’s REDI initiative will provide 25 businesses with a $10,000 subsidy to ease the cost of engaging a PhD student intern through APR.Intern.

These short-term research placements enable innovative businesses to access Australia’s brightest emerging research talent and fast-track R&D. For universities, these placements support the development of an industry-ready PhD workforce.

This partnership falls under MTPConnect’s $32 million Researcher Exchange and Development within Industry (REDI) initiative made possible by the Medical Research Future Fund, providing industry experiences and skills development for early and mid-career researchers, clinicians and innovators to develop an industry ready workforce keeping pace with the demands of a rapidly changing sector. 

PROJECT COSTS

Contact us to discuss how this subsidy can be applied to your project costs.

INTERNSHIP BENEFITS

COST-EFFECTIVE

  • Access to PhD-level research expertise
  • Used for controlled practice growth
  • Suitable to fill short-term skills gaps
  • Eligible for R&D tax incentive

RAPID RESULTS

  • Results-driven 3-6 month projects
  • Quick turnaround on establishment
  • Responsive to changing business needs and priorities

HASSLE FREE

  • IP stays with business
  • No employment requirements
  • Pre-approved contract
  • Simple and transparent model
  • Proven and trusted model

INDUSTRY ELIGIBILITY

  • Proposal must have medtech, biotech or pharmaceutical relevance
  • One MTPConnect REDI subsidy per business
  • Project subject to MTPConnect review and approval

FOR MORE INFORMATION

Michael Valentine
Business Development Manager, APR.Intern

0411 600 063
m.valentine@aprintern.org.au